Table 3 cytokine’s measurement.

From: Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients

 

IL-1RA

IL6

TNFα

IL10

IL8

M_CSF

Elastase

LMOD group D1

1614 ± 3793 (p = 0.06)

2512 ± 3159

95 ± 60

42 ± 28 Ϯ

139 ± 83 *Ϯ

292 ± 174 (p = 0.06)

48 ± 21*

LMOD group D5

58 ± 83

824 ± 1079

64 ± 24

36 ± 16

118 ± 57

152 ± 75

25 ± 8

Control group D1

254 ± 192

1220 ± 2530

61 ± 31

96 ± 120

49 ± 42

137 ± 91

35 ± 27

Control group D5

68 ± 88

93 ± 92

3582 ± 2618

35 ± 20

48 ± 12

65 ± 49

12 ± 3

  1. *p < 0.05 LMOD group D1 vs D5 Friedman test.
  2. |p < 0.05 control group D1 vs D5.
  3. Ϯ p < 0.05 LMOD group D1 vs control group D1.
Back to article page